Session 3: New Pharmacovigilance legislation and genomics
Session 3: Post-approval pharmacogenomics: impact on Risk Management Plans and Information Speaker: Peter Arlett, Head of Sector for Pharmacovigilance and Risk Management, EMA Workshop on Pharmacogenomics: from science to clinical care (8 October 2012)From:emainfoViews:0 0ratingsTime:23:56More inScience Technology
Follow this link:
Session 3: New Pharmacovigilance legislation and genomics – Video